PharMerica (PMC) Tops Q2 EPS by 2c; Rev Guidance Lowered

August 2, 2012 4:14 PM EDT
Get Alerts PMC Hot Sheet
Trade PMC Now!
Join SI Premium – FREE
PharMerica (NYSE: PMC) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $458.5 million versus the consensus estimate of $488.48 million.

FY12 Revenue Guidance Lowered

For earnings history and earnings-related data on PharMerica (PMC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment